IL93242A - Pharmaceutical preparation for the treatment of beta-streptococcal tonsillitis comprising a streptococcus strain - Google Patents

Pharmaceutical preparation for the treatment of beta-streptococcal tonsillitis comprising a streptococcus strain

Info

Publication number
IL93242A
IL93242A IL9324290A IL9324290A IL93242A IL 93242 A IL93242 A IL 93242A IL 9324290 A IL9324290 A IL 9324290A IL 9324290 A IL9324290 A IL 9324290A IL 93242 A IL93242 A IL 93242A
Authority
IL
Israel
Prior art keywords
ncib
strains
streptococci
treatment
pharmaceutical preparation
Prior art date
Application number
IL9324290A
Other languages
English (en)
Other versions
IL93242A0 (en
Original Assignee
Grahn Eva E
Holm Stig Edvin Folke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grahn Eva E, Holm Stig Edvin Folke filed Critical Grahn Eva E
Publication of IL93242A0 publication Critical patent/IL93242A0/xx
Publication of IL93242A publication Critical patent/IL93242A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/885—Streptococcus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL9324290A 1989-02-15 1990-02-01 Pharmaceutical preparation for the treatment of beta-streptococcal tonsillitis comprising a streptococcus strain IL93242A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8900510A SE463349B (sv) 1989-02-15 1989-02-15 Farmaceutiskt preparat foer profylax mot och/eller behandling av beta-streptokockinducerad tonsillit

Publications (2)

Publication Number Publication Date
IL93242A0 IL93242A0 (en) 1990-11-29
IL93242A true IL93242A (en) 1994-11-28

Family

ID=20375049

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9324290A IL93242A (en) 1989-02-15 1990-02-01 Pharmaceutical preparation for the treatment of beta-streptococcal tonsillitis comprising a streptococcus strain

Country Status (28)

Country Link
US (1) US5378459A (xx)
EP (1) EP0458855B1 (xx)
CN (1) CN1046099A (xx)
AR (1) AR247099A1 (xx)
AT (1) ATE142503T1 (xx)
AU (1) AU628493B2 (xx)
CA (1) CA2047189A1 (xx)
CS (1) CS74890A2 (xx)
DD (1) DD291926A5 (xx)
DE (1) DE69028520T2 (xx)
DK (1) DK0458855T3 (xx)
EG (1) EG19075A (xx)
ES (1) ES2091818T3 (xx)
FI (1) FI101452B (xx)
GR (1) GR1000639B (xx)
HU (1) HU209915B (xx)
IE (1) IE900459L (xx)
IL (1) IL93242A (xx)
IS (1) IS1678B (xx)
MY (1) MY106487A (xx)
NO (1) NO178883C (xx)
NZ (1) NZ232381A (xx)
PH (1) PH27203A (xx)
PT (1) PT93141A (xx)
SE (1) SE463349B (xx)
WO (1) WO1990009186A1 (xx)
YU (1) YU23490A (xx)
ZA (1) ZA90692B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5705152A (en) * 1990-10-26 1998-01-06 Interprise Limited Antimicrobial composition
AUPN698495A0 (en) * 1995-12-06 1996-01-04 Pharma Pacific Pty Ltd Improved therapeutic formulation and method
SE511648C2 (sv) * 1998-04-17 1999-11-01 Bacterum Ab Streptokockpreparat för behandling av öroninflammation
DE60034879T8 (de) 1999-10-12 2008-07-03 Blis Technologies Ltd. Lantibiotikum
DE10139039A1 (de) * 2001-08-08 2003-05-08 Zinon Douvlis Medikamentöse Suppression maligner Proliferationsprozesse durch Aminosäuren und Aminosäurenbindungen orientierte Reaktionen
PL2349295T3 (pl) * 2008-11-17 2017-06-30 Winclove Holding B.V. Preparat farmaceutyczny zawierający kombinację szczepów paciorkowców i szczepów lactobacillus
CA3000665C (en) 2015-10-01 2023-10-17 The Governing Council Of The University Of Toronto Iron-fortified tea preparations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1195613A (en) * 1981-02-17 1985-10-22 Forsyth Dental Infirmary For Children Method of treating periodontosis
US4454109A (en) * 1981-02-17 1984-06-12 Forsyth Dental Infirmary For Children Method of treating periodontosis
JPS5927833A (ja) * 1982-08-06 1984-02-14 Advance Res & Dev Co Ltd コレステロール乃至トリグリセリド低下剤

Also Published As

Publication number Publication date
CN1046099A (zh) 1990-10-17
NO913162L (no) 1991-10-07
NZ232381A (en) 1992-10-28
AR247099A1 (es) 1994-11-30
IL93242A0 (en) 1990-11-29
SE463349B (sv) 1990-11-12
IS3547A7 (is) 1990-08-16
NO913162D0 (no) 1991-08-13
FI101452B1 (fi) 1998-06-30
SE8900510D0 (sv) 1989-02-15
US5378459A (en) 1995-01-03
CS74890A2 (en) 1991-09-15
PH27203A (en) 1993-05-04
GR1000639B (el) 1992-09-11
NO178883B (no) 1996-03-18
ZA90692B (en) 1990-10-31
ES2091818T3 (es) 1996-11-16
DK0458855T3 (da) 1996-09-30
CA2047189A1 (en) 1990-08-16
GR900100092A (en) 1991-06-28
FI913845A0 (fi) 1991-08-14
AU628493B2 (en) 1992-09-17
MY106487A (en) 1995-06-30
FI101452B (fi) 1998-06-30
DE69028520D1 (de) 1996-10-17
DD291926A5 (de) 1991-07-18
DE69028520T2 (de) 1997-04-03
EP0458855B1 (en) 1996-09-11
WO1990009186A1 (en) 1990-08-23
SE8900510L (sv) 1990-08-16
HU209915B (en) 1994-11-28
PT93141A (pt) 1990-08-31
ATE142503T1 (de) 1996-09-15
NO178883C (no) 1996-06-26
IS1678B (is) 1997-12-31
EP0458855A1 (en) 1991-12-04
IE900459L (en) 1990-08-15
EG19075A (en) 1994-06-30
YU23490A (sh) 1993-05-28
HUT57051A (en) 1991-11-28
AU5157790A (en) 1990-09-05

Similar Documents

Publication Publication Date Title
Hammond et al. Antimicrobial susceptibility of Haemophilus ducreyi
Roos et al. Interfering α-streptococci as a protection against recurrent streptococcal tonsillitis in children
US4746512A (en) Anticariogenic or antiperiodontitic agent
Falck et al. Tolerance and efficacy of interfering alpha-streptococci in recurrence of streptococcal pharyngotonsillitis: a placebo-controlled study
Rummens et al. In vitro susceptibility of Capnocytophaga species to 29 antimicrobial agents
AU2003206479A1 (en) Antimicrobial composition
Ledbetter et al. The aerobic and anaerobic flora of rattlesnake fangs and venom: therapeutic implications
Brook et al. The treatment of the carrier state of group A beta-hemolytic streptococci with clindamycin
Gaman et al. Emergence of gentamicin-and carbenicillin-resistant Pseudomonas aeruginosa in a hospital environment
US5378459A (en) Pharmaceutical preparation in the treatment of tonsillitis
Buu-Hoi et al. Endocarditis caused by Capnocytophaga ochracea
Aly et al. Bacterial interference among Staphylococcus aureus strains
LeProwse et al. Catheter-related bacteremia caused by Oerskovia turbata
WO2019013401A1 (ko) 락토바실러스 루테리 cs 132(kctc 11452bp) 또는 이의 배양물을 포함하는 구강병원균 억제조성물
Moorhouse et al. Hospital study of transferable drug resistance.
Da Costa et al. Empyema thoracis and lung abscess due to Gemella morbillorum
CN112322553A (zh) 一种抗艰难梭菌的乳酸乳球菌及其应用
US3925160A (en) Method of producing an antibiotic
Hoppe et al. Susceptibility of Bordetellapertussis and Bordetellaparapertussis to 24 Antibiotics
JPS6069022A (ja) 免疫調整剤及びその製造法
WO2023063453A1 (ko) 항생제 내성 슈도모나스균 특이적 박테리오파지
Babiker et al. Pseudomonas aeruginosa in Diabetic Foot Infections, Gadarif Diabetic Center, Sudan (2017-2018)
Devuyst et al. Rarity and potential severity of Gemella haemolysans endocarditis
Lentino et al. Comparative efficacy of cefotiam versus cephalothin in the therapy of skin and soft tissue infections
JPH04503511A (ja) 扁桃炎治療用薬学的調製物

Legal Events

Date Code Title Description
RH Patent void